Paper7753136
The use of estrogens and progestins and the risk of breast cancer in postmenopausal women.
Colditz GA and 8 others. N Engl J Med, 1995. Cited by 1,239 papers, by iCite.
Cite this record
ConductScience Library. The use of estrogens and progestins and the risk of breast cancer in postmenopausal women. Papers, record 7753136. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/7753136
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics16
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Breast Neoplasms | Major topic |
| Estrogen Replacement Therapy | Major topic |
| Estrogens | Major topic |
| Postmenopause | Major topic |
| Progestins | Major topic |
| Aged | |
| Case-Control Studies | |
| Cohort Studies | |
| Confidence Intervals | |
| Female | |
| Follow-Up Studies | |
| Humans | |
| Middle Aged | |
| Prospective Studies | |
| Risk | |
| Risk Factors |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| CA 40956 | NCI NIH HHS | United States | U01CA040956 | PubMed and NIH |
Source NIH RePORTER
Trials2
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
| Trial | Title | The trial lists it as | Named in the paper's record | Source |
|---|---|---|---|---|
| NCT00248989 | Effect of DHEA on Skin Aging in Postmenopausal Women | Background | ClinicalTrials.gov | |
| NCT04051320 | Characterizing the Neural Substrates of Irritability in Women: an Experimental Neuroendocrine Model | Background | ClinicalTrials.gov |
Comments and corrections8
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
| Kind | PMID | Title | In Papers | Source |
|---|---|---|---|---|
| Comment in | 7566032 | Breast cancer and hormone-replacement therapy. | https://conductscience.org/library/papers/7566032 | PubMed |
| Comment in | 7566033 | Breast cancer and hormone-replacement therapy. | https://conductscience.org/library/papers/7566033 | PubMed |
| Comment in | 7566034 | Breast cancer and hormone-replacement therapy. | https://conductscience.org/library/papers/7566034 | PubMed |
| Comment in | 7566035 | Breast cancer and hormone-replacement therapy. | https://conductscience.org/library/papers/7566035 | PubMed |
| Comment in | 7566036 | Breast cancer and hormone-replacement therapy. | https://conductscience.org/library/papers/7566036 | PubMed |
| Comment in | 7566037 | Breast cancer and hormone-replacement therapy. | https://conductscience.org/library/papers/7566037 | PubMed |
| Comment in | 7566038 | Breast cancer and hormone-replacement therapy. | https://conductscience.org/library/papers/7566038 | PubMed |
| Comment in | 7753144 | Hormone-replacement therapy--breast versus heart versus bone. | https://conductscience.org/library/papers/7753144 | PubMed |
Cited by221
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1,239 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41773428 | Hyaluronic acid for vaginal health and quality of life in postmenopausal women: A systematic review and meta-analysis of randomized controlled trials. | Int J Gynaecol Obstet | 2026 | https://conductscience.org/library/papers/41773428 | PubMed |
| 41467203 | Opportunistic salpingectomy during radical cystectomy for bladder cancer: A systematic review of the literature. | Asian J Urol | 2025 | https://conductscience.org/library/papers/41467203 | PubMed |
| 40236653 | Risk factors for breast cancer recurrence in postmenopausal women: a bibliometric study. | Front Oncol | 2025 | https://conductscience.org/library/papers/40236653 | PubMed |
| 39877995 | Development and optimization of raloxifene hydrochloride loaded lipid nanocapsule based hydrogel for transdermal delivery. | Ther Deliv | 2025 | https://conductscience.org/library/papers/39877995 | PubMed |
| 39856672 | Decoding the mechanisms behind second primary cancers. | J Transl Med | 2025 | https://conductscience.org/library/papers/39856672 | PubMed |
| 39522613 | Estrogens and breast cancer. | Ann Oncol | 2025 | https://conductscience.org/library/papers/39522613 | PubMed |
| 39497219 | Menopausal hormone therapy and incidence, mortality, and survival of breast cancer subtypes: a prospective cohort study. | Breast Cancer Res | 2024 | https://conductscience.org/library/papers/39497219 | PubMed |
| 39338410 | Effects, Doses, and Applicability of Gestrinone in Estrogen-Dependent Conditions and Post-Menopausal Women. | Pharmaceuticals (Basel) | 2024 | https://conductscience.org/library/papers/39338410 | PubMed |
| 38001750 | Lobular Carcinoma of the Breast: A Comprehensive Review with Translational Insights. | Cancers (Basel) | 2023 | https://conductscience.org/library/papers/38001750 | PubMed |
| 36714061 | Medical transition for gender diverse patients. | Curr Obstet Gynecol Rep | 2020 | https://conductscience.org/library/papers/36714061 | PubMed |
| 35743654 | Diagnostic Challenge of Invasive Lobular Carcinoma of the Breast: What Is the News? Breast Magnetic Resonance Imaging and Emerging Role of Contrast-Enhanced Spectral Mammography. | J Pers Med | 2022 | https://conductscience.org/library/papers/35743654 | PubMed |
| 35225478 | Validation of Identifying Cancer Diagnosis Based on Self-Reported Information in the Japan Nurses' Health Study. | Asian Pac J Cancer Prev | 2022 | https://conductscience.org/library/papers/35225478 | PubMed |
| 35216504 | Premarin Reduces Neurodegeneration and Promotes Improvement of Function in an Animal Model of Spinal Cord Injury. | Int J Mol Sci | 2022 | https://conductscience.org/library/papers/35216504 | PubMed |
| 34780257 | Running the Female Power Grid Across Lifespan Through Brain Estrogen Signaling. | Annu Rev Physiol | 2022 | https://conductscience.org/library/papers/34780257 | PubMed |
| 34281275 | Less Carcinogenic Chlorinated Estrogens Applicable to Hormone Replacement Therapy. | Int J Mol Sci | 2021 | https://conductscience.org/library/papers/34281275 | PubMed |
| 34006878 | Circulating amino acids and amino acid-related metabolites and risk of breast cancer among predominantly premenopausal women. | NPJ Breast Cancer | 2021 | https://conductscience.org/library/papers/34006878 | PubMed |
| 33958486 | Progesterone promotes immunomodulation and tumor development in the murine mammary gland. | J Immunother Cancer | 2021 | https://conductscience.org/library/papers/33958486 | PubMed |
| 33870115 | Breast Cancer Incidence Reduction in Women Treated with Subcutaneous Testosterone: Testosterone Therapy and Breast Cancer Incidence Study. | Eur J Breast Health | 2021 | https://conductscience.org/library/papers/33870115 | PubMed |
| 33520704 | Lobular Breast Cancer: A Review. | Front Oncol | 2020 | https://conductscience.org/library/papers/33520704 | PubMed |
| 33230972 | Sphingosylphosphorylcholine blocks ovariectomy-induced bone loss by suppressing Ca2+ /calmodulin-mediated osteoclast differentiation. | J Cell Mol Med | 2021 | https://conductscience.org/library/papers/33230972 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/7753136
GET https://conductscience.org/api/papers/v1/7753136/cited_by?page=2